National Medicines Symposium 2024 speakers (L to R): Steve Waller, Professor Jennifer Martin, Professor Libby Roughead, Tegan Taylor[/caption]
This CPD activity is sponsored by Reckitt. All content is the true, accurate and independent opinion of the speakers and the views expressed are entirely their own.[/caption]
With the ever-changing landscape of over-the-counter (OTC) pain management in recent years, it’s important to revisit guideline recommendations to optimally assess and manage patients with acute pain.
Unrelieved acute pain can negatively impact patient well-being, affecting their sleep, physical functioning, and overall quality of life, and increases the risk of transition to chronic pain.1 Applying appropriate evidence-based interventions throughout an acute pain consultation can help pharmacists minimise the risk of inadequate pain management.2,3
In this CPD-accredited podcast, pharmacist John Bell discusses reducing risk in the management of acute low back pain (LBP), alongside a real patient for a first-hand perspective on how pharmacists can apply guideline recommendations to enhance care.
The first step to reduce risk in acute LBP is thorough assessment and history taking to ascertain the impact of the pain.3 This is critical for identifying ‘red flags’ that suggest a serious pathology requiring referral, or ‘yellow flags’ that suggest risk factors for chronicity and may need further attention.3 For patients with acute, mild episodes, this also provides an opportunity to reassure on the benign nature of the pain and favourable prognosis.3
Second
THIS IS A CPD ARTICLE. YOU NEED TO BE A PSA MEMBER AND LOGGED IN TO READ MORE.
